cholestyramine resin has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | cholestyramine resin (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, D; Benson, B; Brown, R; Bullard, S; Chen, L; Collins, J; Grimes, A; Handlon, AL; Klein, R; Kleymenova, E; Krull, D; Liu, Y; McNulty, J; Murray, D; Nystrom, C; Remlinger, K; Yao, X; Young, A | 1 |
1 other study(ies) available for cholestyramine resin and glucagon-like peptide 1
| Article | Year |
|---|---|
Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Cholestyramine Resin; Diabetes Mellitus, Experimental; Gene Expression; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Resistance; Intestinal Mucosa; Liver; Liver X Receptors; Male; Obesity; Orphan Nuclear Receptors; Peptide YY; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear | 2010 |